Inventor
AVERETT DEVRON R
US19 patents
⚠️ This page may combine multiple inventors who share the name “AVERETT DEVRON R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANADYS PHARMACEUTICALS INC
6 patentsUS7576068B2Aug 18, 2009
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
ANADYS PHARMACEUTICALS INC91 citations98
US8034802B2Oct 11, 2011
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
ANADYS PHARMACEUTICALS INC43 citations97
US6924271B2Aug 2, 2005
3-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC123 citations97
US7745415B2Jun 29, 2010
3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC6 citations73
US7321033B2Jan 22, 2008
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC7 citations72
US7943759B2May 17, 2011
3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC3 citations61
AVERETT STEWART BENSON
3 patentsUS9144242B2Sep 29, 2015
Titanium dioxide photocatalytic compositions and uses thereof
AVERETT STEWART BENSON16 citations90
US9055751B2Jun 16, 2015
Titanium dioxide photocatalytic compositions and uses thereof
AVERETT STEWART BENSON11 citations90
US9402400B2Aug 2, 2016
Titanium dioxide photocatalytic compositions and uses thereof
AVERETT STEWART BENSON1 citations60
WELL Shield LLC
3 patentsUS9392795B2Jul 19, 2016
Titanium dioxide photocatalytic compositions and uses thereof
WELL Shield LLC7 citations81
US10434203B2Oct 8, 2019
Reduction of infections in healthcare settings using photocatalytic compositions
WELL Shield LLC2 citations70
US9833003B2Dec 5, 2017
Titanium dioxide photocatalytic compositions and uses thereof
WELL Shield LLC1 citations60
BURROUGHS WELLCOME CO
3 patentsAVERETT DEVRON R
2 patentsUS8211863B2Jul 3, 2012
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
AVERETT DEVRON R14 citations91
US7858637B2Dec 28, 2010
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus
AVERETT DEVRON R10 citations82